{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:16:33Z","timestamp":1791418593491,"version":"4.3.3"},"reference-count":122,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["23K06160"],"award-info":[{"award-number":["23K06160"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>The NF-E2-related factor 2 (Nrf2)-antioxidant response element (ARE) pathway is a potential therapeutic target for central nervous system diseases. This review emphasizes the role of oxidative stress and neuroinflammation in neurodegenerative diseases, highlighting the therapeutic potential of Nrf2 activators such as dimethyl fumarate (DMF). DMF, initially administered for treating psoriasis, has demonstrated efficacy in multiple sclerosis and is metabolized to monomethyl fumarate, which may exert significant therapeutic effects. DMF activates the Nrf2-ARE pathway, and recent studies have indicated that its anti-inflammatory effects occur through Nrf2-independent mechanisms. Electrophilic Nrf2 activators, such as DMF, covalently bind to cysteine residues in proteins and modulate their function. We discuss the implications of cysteine residue modifications by DMF, which may cause both therapeutic benefits and potential off-target effects. Furthermore, we propose a chemical proteomics-based drug discovery approach to achieve desired therapeutic effects by selectively covalently modifying cysteines in target proteins. These findings advocate for a broader understanding of the Nrf2-independent mechanisms of electrophilic Nrf2 activators, thereby improving drug discovery strategies that target neurodegenerative diseases while minimizing toxicity.<\/jats:p>","DOI":"10.3390\/antiox13121527","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T08:10:47Z","timestamp":1734077447000},"page":"1527","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Nrf2-Independent Anti-Inflammatory Effects of Dimethyl Fumarate: Challenges and Prospects in Developing Electrophilic Nrf2 Activators for Neurodegenerative Diseases"],"prefix":"10.3390","volume":"13","author":[{"given":"Yasuhiko","family":"Izumi","sequence":"first","affiliation":[{"name":"Laboratory of Pharmacology, Kobe Pharmaceutical University, 4-19-1 Motoyamakita-machi, Higashinada-ku, Kobe 658-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6508-0094","authenticated-orcid":false,"given":"Yutaka","family":"Koyama","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Kobe Pharmaceutical University, 4-19-1 Motoyamakita-machi, Higashinada-ku, Kobe 658-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e13031","DOI":"10.1111\/acel.13031","article-title":"Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease","volume":"18","author":"Trist","year":"2019","journal-title":"Aging Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jneuroim.2017.01.019","article-title":"Oxidative modifications of blood serum proteins in myasthenia gravis","volume":"305","author":"Galiniak","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Bond, L., Bernhardt, K., Madria, P., Sorrentino, K., Scelsi, H., and Mitchell, C.S. (2018). A Metadata Analysis of Oxidative Stress Etiology in Preclinical Amyotrophic Lateral Sclerosis: Benefits of Antioxidant Therapy. Front. Neurosci., 12.","DOI":"10.3389\/fnins.2018.00010"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Pollari, E., Goldsteins, G., Bart, G., Koistinaho, J., and Giniatullin, R. (2014). The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis. Front. Cell. Neurosci., 8.","DOI":"10.3389\/fncel.2014.00131"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/JHD-160205","article-title":"Oxidative Stress and Huntington\u2019s Disease: The Good, The Bad, and The Ugly","volume":"5","author":"Kumar","year":"2016","journal-title":"J. Huntingt. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Delatycki, M.B., and Bidichandani, S.I. (2019). Friedreich ataxia- pathogenesis and implications for therapies. Neurobiol. Dis., 132.","DOI":"10.1016\/j.nbd.2019.104606"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7191080","DOI":"10.1155\/2020\/7191080","article-title":"Inflammation and Oxidative Stress in Multiple Sclerosis: Consequences for Therapy Development","volume":"2020","author":"Pegoretti","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"16817","DOI":"10.1074\/jbc.R117.800169","article-title":"Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress","volume":"292","author":"Suzuki","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"DeBlasi, J.M., and DeNicola, G.M. (2020). Dissecting the Crosstalk between NRF2 Signaling and Metabolic Processes in Cancer. Cancers, 12.","DOI":"10.3390\/cancers12103023"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Zgorzynska, E., Dziedzic, B., and Walczewska, A. (2021). An Overview of the Nrf2\/ARE Pathway and Its Role in Neurodegenerative Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179592"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/157488912803252023","article-title":"The Nrf2-ARE pathway: A valuable therapeutic target for the treatment of neurodegenerative diseases","volume":"7","author":"Joshi","year":"2012","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2015.07.147","article-title":"Nrf2\u2014A therapeutic target for the treatment of neurodegenerative diseases","volume":"88","author":"Johnson","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1759091419899782","DOI":"10.1177\/1759091419899782","article-title":"NRF2 as a therapeutic target in neurodegenerative diseases","volume":"12","author":"Brandes","year":"2020","journal-title":"ASN Neuro"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"175025","DOI":"10.1016\/j.ejphar.2022.175025","article-title":"Dimethyl fumarate: A review of preclinical efficacy in models of neurodegenerative diseases","volume":"926","author":"Majkutewicz","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/nen.0b013e31802d6da9","article-title":"Expression of Nrf2 in neurodegenerative diseases","volume":"66","author":"Ramsey","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.redox.2017.07.006","article-title":"NRF2 deficiency replicates transcriptomic changes in Alzheimer\u2019s patients and worsens APP and TAU pathology","volume":"13","author":"Rojo","year":"2017","journal-title":"Redox Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.redox.2018.07.006","article-title":"Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy","volume":"18","author":"Rojo","year":"2018","journal-title":"Redox Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"16505","DOI":"10.1073\/pnas.0908397106","article-title":"Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer\u2019s disease","volume":"106","author":"Kanninen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1073\/pnas.0813361106","article-title":"Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson\u2019s disease: Critical role for the astrocyte","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/glia.20947","article-title":"Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson\u2019s disease","volume":"58","author":"Rojo","year":"2010","journal-title":"Glia"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.freeradbiomed.2010.07.013","article-title":"Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions","volume":"49","author":"Drexhage","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"ref_23","first-page":"1503","article-title":"Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis","volume":"22","author":"Larabee","year":"2016","journal-title":"Mol. Vis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/toxsci\/kfp274","article-title":"The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis","volume":"114","author":"Johnson","year":"2010","journal-title":"Toxicol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1167\/iovs.17-22972","article-title":"SIRT1 and NRF2 Gene Transfer Mediate Distinct Neuroprotective Effects Upon Retinal Ganglion Cell Survival and Function in Experimental Optic Neuritis","volume":"59","author":"McDougald","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/NEN.0b013e31818b4906","article-title":"Nuclear erythroid 2-related factor 2-antioxidative response element signaling pathway in motor cortex and spinal cord in amyotrophic lateral sclerosis","volume":"67","author":"Sarlette","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/labinvest.2013.73","article-title":"The modest impact of transcription factor Nrf2 on the course of disease in an ALS animal model","volume":"93","author":"Guo","year":"2013","journal-title":"Lab. Investig."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13574","DOI":"10.1523\/JNEUROSCI.4099-08.2008","article-title":"Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis","volume":"28","author":"Vargas","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1073\/pnas.0408487101","article-title":"Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription","volume":"102","author":"Calkins","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"22925","DOI":"10.1074\/jbc.M414635200","article-title":"Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo","volume":"280","author":"Shih","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Petrillo, S., Piermarini, E., Pastore, A., Vasco, G., Schirinzi, T., Carrozzo, R., Bertini, E., and Piemonte, F. (2017). Nrf2-Inducers Counteract Neurodegeneration in Frataxin-Silenced Motor Neurons: Disclosing New Therapeutic Targets for Friedreich\u2019s Ataxia. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18102173"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Paupe, V., Dassa, E.P., Goncalves, S., Auch\u00e8re, F., L\u00f6nn, M., Holmgren, A., and Rustin, P. (2009). Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0004253"},{"key":"ref_33","first-page":"103","article-title":"Heilung von Psoriasis vulgaris","volume":"13","author":"Schweckendiek","year":"1959","journal-title":"Med. Monatschr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0190-9622(89)70071-2","article-title":"Systemic therapy with fumaric acid derivatives: New possibilities in the treatment of psoriasis","volume":"20","author":"Nieboer","year":"1989","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1468-1331.2006.01292.x","article-title":"Oral fumaric acid esters for the treatment of active multiple sclerosis: An open-label, baseline-controlled pilot study","volume":"13","author":"Schimrigk","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2133.2003.05433.x","article-title":"Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis","volume":"149","author":"Hoefnagel","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1007\/s00204-020-02788-1","article-title":"Molecular basis of mood and cognitive adverse events elucidated via a combination of pharmacovigilance data mining and functional enrichment analysis","volume":"94","author":"Andronis","year":"2020","journal-title":"Arch. Toxicol."},{"key":"ref_39","first-page":"20552173221132469","article-title":"Progressive multifocal leukoencephalopathy outcomes in patients with multiple sclerosis treated with dimethyl fumarate","volume":"8","author":"Lyons","year":"2022","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Litjens, N.H., van Strijen, E., van Gulpen, C., Mattie, H., van Dissel, J.T., Thio, H.B., and Nibbering, P.H. (2004). In vitro pharmacokinetics of anti-psoriatic fumaric acid esters. BMC Pharmacol., 4.","DOI":"10.1186\/1471-2210-4-22"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tips.2017.11.002","article-title":"The Pharmacokinetics of Fumaric Acid Esters Reveal Their In Vivo Effects","volume":"39","author":"Mrowietz","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2125.2004.02145.x","article-title":"Pharmacokinetics of oral fumarates in healthy subjects","volume":"58","author":"Litjens","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00403-010-1061-4","article-title":"Pharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patients","volume":"302","author":"Clement","year":"2010","journal-title":"Arch. Dermatol. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1073\/pnas.1603907113","article-title":"Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2","volume":"113","author":"Pekarek","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2249.2006.03094.x","article-title":"Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration","volume":"145","author":"Schilling","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1084\/jem.20100977","article-title":"Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells","volume":"208","author":"Ghoreschi","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awq386","article-title":"Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway","volume":"134","author":"Linker","year":"2011","journal-title":"Brain"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bbrc.2008.08.041","article-title":"The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist","volume":"375","author":"Tang","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.molmed.2015.02.002","article-title":"Nutritional or pharmacological activation of HCA(2) ameliorates neuroinflammation","volume":"21","author":"Offermanns","year":"2015","journal-title":"Trends Mol. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2012.06.003","article-title":"Role of HCA2 (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skin","volume":"136","author":"Hanson","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00401-015-1422-3","article-title":"Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS","volume":"130","author":"Parodi","year":"2015","journal-title":"Acta Neuropathol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1172\/JCI72151","article-title":"Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate\u2019s protective effect in EAE","volume":"124","author":"Chen","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.msard.2018.04.016","article-title":"Dimethyl fumarate downregulates the immune response through the HCA(2)\/GPR109A pathway: Implications for the treatment of multiple sclerosis","volume":"23","author":"Moraes","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1742-2094-9-163","article-title":"Effects of dimethyl fumarate on neuroprotection and immunomodulation","volume":"9","author":"Albrecht","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/jcmm.13358","article-title":"Multiple mechanisms of dimethyl fumarate in amyloid \u03b2-induced neurotoxicity in human neuronal cells","volume":"22","author":"Campolo","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jneuroim.2015.04.006","article-title":"DMF, but not other fumarates, inhibits NF-kappaB activity in vitro in an Nrf2-independent manner","volume":"283","author":"Gillard","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"rs10","DOI":"10.1126\/scisignal.aaf7694","article-title":"Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells","volume":"9","author":"Blewett","year":"2016","journal-title":"Sci. Signal."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.4049\/jimmunol.1801627","article-title":"Dimethyl fumarate disrupts human innate immune signaling by targeting the IRAK4-MyD88 complex","volume":"202","author":"Zaro","year":"2019","journal-title":"J. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Tang, J., Zhou, Y., Xiao, Q., Chen, Q., Wang, H., Lan, J., Wu, L., and Peng, Y. (2023). Short-term exposure to dimethyl fumarate (DMF) inhibits LPS-induced IkappaBzeta expression in macrophages. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1114897"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bmc.2006.09.053","article-title":"Reactivity of dimethyl fumarate and methylhydrogen fumarate towards glutathione and N-acetyl-L-cysteine\u2014Preparation of S-substituted thiosuccinic acid esters","volume":"15","author":"Schmidt","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/bdd.364","article-title":"Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters","volume":"24","author":"Werdenberg","year":"2003","journal-title":"Biopharm. Drug Dispos."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/j.jasms.2007.09.015","article-title":"Sites of alkylation of human Keap1 by natural chemoprevention agents","volume":"18","author":"Luo","year":"2007","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Brennan, M.S., Matos, M.F., Li, B., Hronowski, X., Gao, B., Juhasz, P., Rhodes, K.J., and Scannevin, R.H. (2015). Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120254"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbrc.2022.03.059","article-title":"Characterization of the modification of Kelch-like ECH-associated protein 1 by different fumarates","volume":"605","author":"Qu","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.1523\/JNEUROSCI.0426-16.2016","article-title":"Distinct Nrf2 signaling mechanisms of fumaric acid esters and their role in neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced experimental Parkinson\u2019s like disease","volume":"36","author":"Ahuja","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.freeradbiomed.2007.03.028","article-title":"Regulation of Nox and Duox enzymatic activity and expression","volume":"43","author":"Lambeth","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20060943","article-title":"Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages","volume":"203","author":"Powers","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"24233","DOI":"10.1074\/jbc.M212389200","article-title":"Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: Evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase","volume":"278","author":"Takada","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cell.2016.08.064","article-title":"Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages","volume":"167","author":"Mills","year":"2016","journal-title":"Cell"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","article-title":"Nrf2 signaling pathway: Pivotal roles in inflammation","volume":"1863","author":"Ahmed","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.bbrc.2006.10.102","article-title":"Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide","volume":"351","author":"Thimmulappa","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nm0196-87","article-title":"Heme oxygenase: A novel target for the modulation of the inflammatory response","volume":"2","author":"Willis","year":"1996","journal-title":"Nat. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1084\/jem.20060845","article-title":"Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts","volume":"203","author":"Nakahira","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1165\/rcmb.2005-0154OC","article-title":"CCAAT\/enhancer-binding protein mediates carbon monoxide-induced suppression of cyclooxygenase-2","volume":"35","author":"Suh","year":"2006","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"20621","DOI":"10.1074\/jbc.M607954200","article-title":"Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress","volume":"282","author":"Lin","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bbamcr.2008.01.002","article-title":"NF-kappaB\/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK","volume":"1783","author":"Liu","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1074\/jbc.M110.162008","article-title":"Nrf2 induces interleukin-6 (IL-6) expression via an antioxidant response element within the IL-6 promoter","volume":"286","author":"Wruck","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"11624","DOI":"10.1038\/ncomms11624","article-title":"Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.bcp.2008.07.036","article-title":"Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway","volume":"76","author":"Lin","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jphs.2022.02.004","article-title":"TPNA10168, an Nrf-2 activator, attenuates inflammatory responses independently of Nrf2 in microglial BV-2 cells: Involvement of the extracellular-signal-regulated kinase pathway","volume":"149","author":"Izumi","year":"2022","journal-title":"J. Pharmacol. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"McGuire, V.A., Ruiz-Zorrilla Diez, T., Emmerich, C.H., Strickson, S., Ritorto, M.S., Sutavani, R.V., Wei\u00df, A., Houslay, K.F., Knebel, A., and Meakin, P.J. (2016). Dimethyl fumarate blocks pro-inflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation. Sci. Rep., 6.","DOI":"10.1038\/srep31159"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.4049\/jimmunol.2100488","article-title":"4-Octyl-Itaconate and dimethyl fumarate inhibit COX2 expression and prostaglandin production in macrophages","volume":"207","author":"Diskin","year":"2021","journal-title":"J. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"L326","DOI":"10.1152\/ajplung.90624.2008","article-title":"Dimethylfumarate inhibits NF-\u03baB function at multiple levels to limit airway smooth muscle cell cytokine secretion","volume":"297","author":"Seidel","year":"2009","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/emboj\/cdg139","article-title":"Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1)","volume":"22","author":"Vermeulen","year":"2003","journal-title":"EMBO J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00011-011-0316-7","article-title":"Dimethylfumarate inhibits MIF-induced proliferation of keratinocytes by inhibiting MSK1 and RSK1 activation and by inducing nuclear p-c-Jun (S63) and p-p53 (S15) expression","volume":"60","author":"Gesser","year":"2011","journal-title":"Inflamm. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"28017","DOI":"10.1074\/jbc.M112.383380","article-title":"Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor \u03baB (NF-\u03baB) and extracellular signal-regulated kinase 1 and 2 (ERK1\/2) and mitogen stress-activated kinase 1 (MSK1) signaling","volume":"287","author":"Peng","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1074\/jbc.M115.679704","article-title":"Dimethyl fumarate inhibits the nuclear factor kappaB pathway in breast cancer cells by covalent modification of p65 protein","volume":"291","author":"Kastrati","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1038\/s41467-018-06787-w","article-title":"Dimethyl fumarate is an allosteric covalent inhibitor of the p90 ribosomal S6 kinases","volume":"9","author":"Andersen","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/cdd.2017.17","article-title":"The role of hybrid ubiquitin chains in the MyD88 and other innate immune signalling pathways","volume":"24","author":"Cohen","year":"2017","journal-title":"Cell Death Differ."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"McAulay, K., Bilsland, A., and Bon, M. (2022). Reactivity of covalent fragments and their role in fragment based drug discovery. Pharmaceuticals, 15.","DOI":"10.3390\/ph15111366"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2337\/db07-0838","article-title":"Inactivation of glyceraldehyde-3-phosphate dehydrogenase by fumarate in diabetes: Formation of S-(2-succinyl)cysteine, a novel chemical modification of protein and possible biomarker of mitochondrial stress","volume":"57","author":"Blatnik","year":"2008","journal-title":"Diabetes"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1126\/science.aan4665","article-title":"Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity","volume":"360","author":"Kornberg","year":"2018","journal-title":"Science"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1042\/BJ20131581","article-title":"Identification of protein succination as a novel modification of tubulin","volume":"462","author":"Piroli","year":"2014","journal-title":"Biochem. J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1074\/mcp.RA118.000922","article-title":"Identification of novel protein targets of dimethyl fumarate modification in neurons and astrocytes reveals actions independent of Nrf2 stabilization","volume":"18","author":"Piroli","year":"2019","journal-title":"Mol. Cell Proteomics"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nature09472","article-title":"Quantitative reactivity profiling predicts functional cysteines in proteomes","volume":"468","author":"Weerapana","year":"2010","journal-title":"Nature"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nature18002","article-title":"Proteome-wide covalent ligand discovery in native biological systems","volume":"534","author":"Backus","year":"2016","journal-title":"Nature"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1021\/tx0502138","article-title":"Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane","volume":"18","author":"Hong","year":"2005","journal-title":"Chem. Res. Toxicol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1021\/tx100389r","article-title":"Modification of keap1 cysteine residues by sulforaphane","volume":"24","author":"Hu","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.bmcl.2005.03.031","article-title":"Studies on the reactivity of CDDO, a promising new chemopreventive and chemotherapeutic agent: Implications for a molecular mechanism of action","volume":"15","author":"Couch","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"Akizawa","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41573-022-00542-z","article-title":"Advances in covalent drug discovery","volume":"21","author":"Boike","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4155\/fmc-2020-0236","article-title":"10 years into the resurgence of covalent drugs","volume":"13","year":"2021","journal-title":"Future Med. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1021\/acs.jmedchem.9b01180","article-title":"Discovery of a covalent inhibitor of KRAS(G12C) (AMG 510) for the treatment of solid tumors","volume":"63","author":"Lanman","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"9367","DOI":"10.1073\/pnas.97.17.9367","article-title":"Site-directed ligand discovery","volume":"97","author":"Erlanson","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature12796","article-title":"K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions","volume":"503","author":"Ostrem","year":"2013","journal-title":"Nature"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/med.21925","article-title":"KEAP1-NRF2 protein-protein interaction inhibitors: Design, pharmacological properties and therapeutic potential","volume":"43","author":"Crisman","year":"2023","journal-title":"Med. Res. Rev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1021\/ml300041g","article-title":"Anti-inflammatory effect of a cell-penetrating peptide targeting the Nrf2\/Keap1 interaction","volume":"3","author":"Steel","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"14727","DOI":"10.1523\/JNEUROSCI.1304-15.2015","article-title":"Cell-permeable peptide targeting the Nrf2-Keap1 interaction: A potential novel therapy for global cerebral ischemia","volume":"35","author":"Tu","year":"2015","journal-title":"J. Neurosci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1021\/acs.joc.9b02367","article-title":"Development of a cell-permeable cyclic peptidyl inhibitor against the Keap1-Nrf2 interaction","volume":"85","author":"Salim","year":"2020","journal-title":"J. Org. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"8088","DOI":"10.1021\/acs.jmedchem.8b00358","article-title":"Non-covalent small-molecule Kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 (Keap1-Nrf2) inhibitors and their potential for targeting central nervous system diseases","volume":"61","author":"Pallesen","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1021\/acs.jmedchem.9b00723","article-title":"A comparative assessment study of known small-molecule Keap1-Nrf2 protein-protein interaction inhibitors: Chemical synthesis, binding properties, and cellular activity","volume":"62","author":"Tran","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"120111","DOI":"10.1016\/j.lfs.2021.120111","article-title":"Nrf2\/Keap1\/ARE signaling: Towards specific regulation","volume":"291","author":"Ulasov","year":"2022","journal-title":"Life Sci."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Georgakopoulos, N.D., Frison, M., Alvarez, M.S., Bertrand, H., Wells, G., and Campanella, M. (2017). Reversible Keap1 inhibitors are preferential pharmacological tools to modulate cellular mitophagy. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-07679-7"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.cellsig.2010.06.004","article-title":"Suppression of NF-kappaB signaling by KEAP1 regulation of IKKbeta activity through autophagic degradation and inhibition of phosphorylation","volume":"22","author":"Kim","year":"2010","journal-title":"Cell. Signal."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.molcel.2009.07.025","article-title":"KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta","volume":"36","author":"Lee","year":"2009","journal-title":"Mol. Cell"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.molcel.2009.04.029","article-title":"Direct interaction between Nrf2 and p21(Cip1\/WAF1) upregulates the Nrf2-mediated antioxidant response","volume":"34","author":"Chen","year":"2009","journal-title":"Mol. Cell"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1128\/MCB.00248-10","article-title":"A noncanonical mechanism of Nrf2 activation by autophagy deficiency: Direct interaction between Keap1 and p62","volume":"30","author":"Lau","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2174\/0115672018260113231023064614","article-title":"Mechanism of action and related natural regulators of Nrf2 in nonalcoholic fatty liver disease","volume":"21","author":"Yu","year":"2024","journal-title":"Curr. Drug Deliv."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Tossetta, G., Fantone, S., Togni, L., Santarelli, A., Olivieri, F., Marzioni, D., and Rippo, M.R. (2024). Modulation of NRF2\/KEAP1 signaling by phytotherapeutics in periodontitis. Antioxidants, 13.","DOI":"10.3390\/antiox13101270"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Gonzalez-Donquiles, C., Alonso-Molero, J., Fernandez-Villa, T., Vilorio-Marqu\u00e9s, L., Molina, A.J., and Mart\u00edn, V. (2017). The NRF2 transcription factor plays a dual role in colorectal cancer: A systematic review. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0177549"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Xia, L., Ma, W., Afrashteh, A., Sajadi, M.A., Fakheri, H., and Valilo, M. (2023). The nuclear factor erythroid 2-related factor 2\/p53 axis in breast cancer. Biochem. Med., 33.","DOI":"10.11613\/BM.2023.030504"}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/13\/12\/1527\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:54:37Z","timestamp":1760115277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/13\/12\/1527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":122,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["antiox13121527"],"URL":"https:\/\/doi.org\/10.3390\/antiox13121527","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]}}}